Literature DB >> 19202461

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.

Jean-Chrysostome Gody, Charlotte Charpentier, Olivia Mbitikon, Ali Si-Mohamed, Jérome LeGoff, Gérard Grésenguet, Laurent Bélec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19202461     DOI： 10.1097/QAI.0b013e318183acae

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  14 in total

1.  Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.

Authors:  William I Towler; Linda Barlow-Mosha; Jessica D Church; Danstan Bagenda; Patrick Ajuna; Micheal Mubiru; Philippa Musoke; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

2.  Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.

Authors:  Theodore D Ruel; Moses R Kamya; Pelin Li; William Pasutti; Edwin D Charlebois; Teri Liegler; Grant Dorsey; Philip J Rosenthal; Diane V Havlir; Joseph K Wong; Jane Achan
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

3.  High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children.

Authors:  M H W Huibers; P Moons; M Cornelissen; F Zorgdrager; N Maseko; M B Gushu; O H Iwajomo; M Boele van Hensbroek; J C J Calis
Journal:  J Antimicrob Chemother       Date:  2018-12-01       Impact factor: 5.790

4.  It is time to consider third-line options in antiretroviral-experienced paediatric patients?

Authors:  Gert U van Zyl; Helena Rabie; James J Nuttall; Mark F Cotton
Journal:  J Int AIDS Soc       Date:  2011-11-15       Impact factor: 5.396

5.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

Review 6.  Management of paediatric HIV-1 resistance.

Authors:  Ravindra K Gupta; Diana M Gibb; Deenan Pillay
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

7.  Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding.

Authors:  Sandrine Moussa; Mohammad-Ali Jenabian; Jean Chrysostome Gody; Josiane Léal; Gérard Grésenguet; Alain Le Faou; Laurent Bélec
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

8.  Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic.

Authors:  Robert Sebunya; Victor Musiime; Sabrina Bakeera Kitaka; Grace Ndeezi
Journal:  AIDS Res Ther       Date:  2013-11-11       Impact factor: 2.250

9.  The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.

Authors:  Rachel C Vreeman; Michael L Scanlon; Megan S McHenry; Winstone M Nyandiko
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

10.  High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.

Authors:  Mounerou Salou; Anoumou Y Dagnra; Christelle Butel; Nicole Vidal; Laetitia Serrano; Elom Takassi; Abla A Konou; Spero Houndenou; Nina Dapam; Assetina Singo-Tokofaï; Palokinam Pitche; Yao Atakouma; Mireille Prince-David; Eric Delaporte; Martine Peeters
Journal:  J Int AIDS Soc       Date:  2016-04-27       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.